Thomas Jay Lowery
Chief Tech/Sci/R&D Officer bei Satellite Biosciences, Inc.
Profil
Thomas Jay Lowery is currently the Chief Technology Officer at Satellite Biosciences, Inc. Previously, he worked as the Vice President-Diagnostics Research & Development at T2 Biosystems, Inc. He received his undergraduate degree from Brigham Young University and his doctorate from the University of California, Berkeley.
Aktive Positionen von Thomas Jay Lowery
| Unternehmen | Position | Beginn |
|---|---|---|
Satellite Biosciences, Inc.
 Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Chief Tech/Sci/R&D Officer | 01.08.2020 |
Ehemalige bekannte Positionen von Thomas Jay Lowery
| Unternehmen | Position | Ende |
|---|---|---|
| T2 BIOSYSTEMS, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Thomas Jay Lowery
| Brigham Young University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| T2 BIOSYSTEMS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Health Technology |